ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Prostate Cancer: NIH Pans To Ramp Up Prostate Cancer Research Funding

June 25, 1999

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

ASCO Members Pick Schilsky as President-Elect; Five Elected to Society’s Board of Directors.

February 16, 2007

Critics Told To Back Waste Charges Or Shut Up

November 23, 1974

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979